AI at Work edition

AI at Work · 22 Oct 2026

22 Oct 2026 · 15 articles

Use one Zapier MCP server across all your AI tools

Most teams don't stick to one AI tool. Your support team works in Claude, a few people swear by ChatGPT, and your engineers live in Cursor. Until now, each of those tools needed its own Zapier MCP server, with its own apps and skills to set up. Now you can connect all of them to one Zapier MCP server, and they share everything on it. Set up your apps and skills once Say your support team uses…

Summary published by The Zapier Blog · 20 Oct 2026 · Read the original ↗

How a recruiting agency uses Claude and Zapier MCP to find the candidates who aren't looking

Curtis Key has been building automation for about 20 years, first with basic code and scripts, then in Salesforce at a real estate brokerage that grew from 8 to 105 agents. But when hiring became the brokerage's hardest problem, he founded Blue Castle Agency, a recruitment firm exclusively for real estate and property management. Curtis keeps one idea in front of the team: the best candidates…

Summary published by The Zapier Blog · 22 Oct 2026 · Read the original ↗

Anthropic takes on Muse with Claude Duet, its new AI agent

Anthropic just announced an AI agent competitor to Meta's Muse and OpenAI's Dots: Claude Duet. The new agent, designed for professionals and small business owners, is launching as a "research preview," according to Anthropic, and it's available as a standalone app on iOS and Android and through Claude on the web. The AI agent is

Summary published by AI | The Verge · 21 Oct 2026 · Read the original ↗

Walmart is inviting AI agents to shop for you

Walmart will soon let AI agents shop on its website for you. Next month, the retail giant will allow you to use an AI agent on the site, with systems in place to let you approve and review purchases and set spending limits. The embrace of AI agents stands in stark contrast to Amazon, which

Summary published by AI | The Verge · 21 Oct 2026 · Read the original ↗

OpenAI acquires Orchestra Bio to build AI agents that speed up drug development

OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind. The goal is to build AI agents that help pharma teams coordinate drug development, from tracking trials to spotting problems. Developing a new drug in the US takes ten to 15 years on average. OpenAI already works with Novo Nordisk and Moderna on AI-driven pharma research.

Summary published by The Decoder · 21 Oct 2026 · Read the original ↗

How to implement AI training for employees

Most teams don't struggle to implement AI in their daily workflows because they're resistant to change—they struggle because they haven't been given the structure to learn how to use it effectively. Employees who receive formal AI training are far more likely to see it as a boost to their productivity and efficiency. Yet while 63% of executives think AI literacy is valuable for their workforce…

Summary published by The Zapier Blog · 21 Oct 2026 · Read the original ↗

Google’s more personalized Gemini AI is heading to your car

Google is bringing Personal Intelligence to Gemini AI in your car. With this update, Gemini in Android Auto and cars with Google built-in can tap into your information across Google apps, including Gmail, Calendar, Maps, Photos, YouTube, and Search. As an example, Google says you can ask Gemini about your flight status if you're driving

Summary published by AI | The Verge · 20 Oct 2026 · Read the original ↗

OpenAI acquires Orchestra Bio

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

Summary published by OpenAI News · 20 Oct 2026 · Read the original ↗